Clinical Trials

Find a Trial

Trial Summary

Protocol No.IUSCC-0582
StatusOPEN TO ACCRUAL
Principal InvestigatorEllsworth, Susannah
ScopeLocal
PhaseNA
Age GroupAdult
TitleANALYSIS OF IMMUNE STATUS FOLLOWING HYPOFRACTIONATED VS. CONVENTIONALLY FRACTIONATED RADIATION THERAPY
DescriptionThe primary objective of this study is to investigate whether hypofractionated radiation therapy as compared to conventionally fractionated radiation therapy is associated with higher absolute lymphocyte counts at one month following the completion of radiation therapy.
Key EligibilityIn order to be eligible to take part in this trial, patients must have:
  • Histologically confirmed solid malignancy (carcinoma/sarcoma/melanoma)
  • Life expectancy ≥ 3 months
  • For a full list of participation criteria, please visit ClinicalTrials.gov
Applicable Disease SitesAny Site
Participating InstitutionsIndiana University (IU)
  • IU Health Methodist Hospital
  • IU Health West (For use by Cancer Center CTO only)
  • Indiana University Hospital / IU Simon Cancer Center
Treatment TypeBasic Science
ContactPhone: (317) 278-5632
Email: iutrials@iu.edu